These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 24829059

  • 1. KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice.
    Koga T, Mizui M, Yoshida N, Otomo K, Lieberman LA, Crispín JC, Tsokos GC.
    Autoimmunity; 2014 Nov; 47(7):445-50. PubMed ID: 24829059
    [Abstract] [Full Text] [Related]

  • 2. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.
    Koga T, Sato T, Furukawa K, Morimoto S, Endo Y, Umeda M, Sumiyoshi R, Fukui S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Origuchi T, Nakamura H, Kawakami A.
    Arthritis Rheumatol; 2019 May; 71(5):766-772. PubMed ID: 30462889
    [Abstract] [Full Text] [Related]

  • 3. Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV.
    Ichinose K, Juang YT, Crispín JC, Kis-Toth K, Tsokos GC.
    Arthritis Rheum; 2011 Feb; 63(2):523-9. PubMed ID: 20954187
    [Abstract] [Full Text] [Related]

  • 4. Calcium/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus.
    Koga T, Ichinose K, Mizui M, Crispín JC, Tsokos GC.
    J Immunol; 2012 Oct 01; 189(7):3490-6. PubMed ID: 22942433
    [Abstract] [Full Text] [Related]

  • 5. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z, Wong CK, Dong J, Chu M, Jiao D, Kam NW, Lam CW, Tam LS.
    Clin Exp Immunol; 2015 Aug 01; 181(2):253-66. PubMed ID: 25845911
    [Abstract] [Full Text] [Related]

  • 6. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
    Xiao ZY, Chen SH, Cheng JP, Zhou WX, Zhang YX, Yang RF, Yun LH.
    Arthritis Res Ther; 2012 Nov 01; 14(6):R235. PubMed ID: 23116248
    [Abstract] [Full Text] [Related]

  • 7. Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15.
    Yang CH, Tian L, Ling GS, Trendell-Smith NJ, Ma L, Lo CK, Stott DI, Liew FY, Huang FP.
    Eur J Immunol; 2008 Jun 01; 38(6):1664-76. PubMed ID: 18465774
    [Abstract] [Full Text] [Related]

  • 8. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu.
    Divekar AA, Dubey S, Gangalum PR, Singh RR.
    J Immunol; 2011 Jan 15; 186(2):924-30. PubMed ID: 21149603
    [Abstract] [Full Text] [Related]

  • 9. Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL/lpr mice by inhibiting expression of Ca(2+)/calmodulin-dependent protein kinase-4.
    Shui B, Xia W, Wen C, Ding X.
    J Nat Med; 2015 Jul 15; 69(3):349-57. PubMed ID: 25821132
    [Abstract] [Full Text] [Related]

  • 10. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V, Monneaux F, Décossas M, Muller S.
    Arthritis Rheum; 2008 Jun 15; 58(6):1751-61. PubMed ID: 18512811
    [Abstract] [Full Text] [Related]

  • 11. Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice.
    Otomo K, Koga T, Mizui M, Yoshida N, Kriegel C, Bickerton S, Fahmy TM, Tsokos GC.
    J Immunol; 2015 Dec 15; 195(12):5533-7. PubMed ID: 26561550
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. TARGETING TARGETED TREATMENT FOR IMMUNE AND NON-IMMUNE KIDNEY DISEASES.
    Tsokos GC, Tsokos MG.
    Trans Am Clin Climatol Assoc; 2019 Dec 15; 130():88-99. PubMed ID: 31516171
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ, Li H, Jiang B, Nandakumar KS, Liu KF, Liu LX, Yu XC, Tan HJ, Zhou C.
    Phytomedicine; 2019 Sep 15; 62():152965. PubMed ID: 31129432
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapy for pneumonitis and sialadenitis by accumulation of CCR2-expressing CD4+CD25+ regulatory T cells in MRL/lpr mice.
    Hasegawa H, Inoue A, Muraoka M, Yamanouchi J, Miyazaki T, Yasukawa M.
    Arthritis Res Ther; 2007 Sep 15; 9(1):R15. PubMed ID: 17284325
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.